Sanofi and Kling Bio have entered into a partnership aimed at accelerating the discovery of neutralising antibodies. The ...

Novartis and Matchpoint Therapeutics have entered into a partnership worth $1bn to develop oral inhibitors for inflammatory ...

GSK’s Blenrep (belantamab mafodotin) combinations have been approved by the European Commission (EC) to treat adults with relapsed or refractory multiple myeloma.

LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with moderate-to-severe chronic hand eczema (CHE). Patients eligible for the ...

We are thrilled to announce that Medscape Education has been honored with the SILVER Award in the Patient Education ...

AstraZeneca (AZ) has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into ...

Biogen has unveiled plans to invest an additional $2bn in its existing manufacturing footprint in North Carolina, US. The ...

Eli Lilly and Almirall’s Ebglyss (lebrikizumab) has been shown to significantly improve the signs and symptoms of atopic ...

Rain Free Days® is a free migraine support app created by Teva, 11 London, and the migraine community. It helps users track ...

Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, ...

Johnson & Johnson (J&J) has announced that its CD38-directed antibody Darzalex (daratumumab) has been approved by the ...